Advertisement · 728 × 90

Posts by Simion Kreimer

I advertised slow n steady LC columns, got 4 preorders.

2 weeks ago 2 0 1 0

Is the world too fast? Are you buried under mountains of spectra? Introducing Classique Chromatagraphy Columns from OniTopics for slow and steady LC-MS. These ARE your granny's columns! Each bead is hand chisled like in the Old Country. Slow down and savor each analyte for a full minute of elution.

3 weeks ago 4 1 0 1

The biggest amino acid gets the biggest letter (double the size of an average letter). That's how I remember it.

4 months ago 1 0 0 0

I went to a Baltimore chess club, got back to the hotel at 3 am.

10 months ago 3 0 0 0

That looks like it causes Emphysema.

11 months ago 0 0 0 0

You should definitely use DTSC

11 months ago 3 0 0 0
Preview
Toward Real-Time Proteomics: Blood to Biomarker Quantitation in under One Hour Multistep multihour tryptic proteolysis has limited the utility of bottom-up proteomics for cases that require immediate quantitative information. The power of proteomics to quantify biomarkers of health status cannot practically assist in clinical care if the dynamics of disease outpaces the turnaround of analysis. The recently available hyperthermoacidic archaeal (HTA) protease “Krakatoa” digests samples in a single 5 to 30 min step at pH 3 and >80 °C in conditions that disrupt most cells and tissues, denature proteins, and block disulfide reformation thereby dramatically expediting and simplifying sample preparation. The combination of quick single-step proteolysis with high-throughput dual-trapping single analytical column (DTSC) liquid chromatography–mass spectrometry (LC–MS) returns actionable data in less than 1 h from collection of unprocessed biofluid. The systematic evaluation of this methodology finds that over 160 proteins are quantified in less than 1 h from 1 μL of whole blood. Furthermore, labile Angiotensin I and II bioactive peptides along with a panel of protein species can be measured at 8 min intervals with a 20 min initial lag using targeted MS. With these methods, we analyzed serum and plasma from 53 individuals and quantified Angiotensin I and II and over 150 proteins including at least 46 that were not detected with trypsin. We discuss some of the implications of real-time proteomics including the immediate potential to advance several clinical and research applications.

Awesome paper, where we present and evaluate the methodology that will someday enable real-time monitoring of circulating biomarkers. pubs.acs.org/doi/full/10....

1 year ago 5 4 0 0
Advertisement

I learned proteomics from a wizard in a Peruvian cave.

1 year ago 4 0 0 0
Post image

Oh snap! leaked content from my presentation at the USHUPO Biopharm Drug Development session 10 today. Stop by if sequence is life.

1 year ago 0 0 0 0

Thank you for the warm reception team MS. Already 38 followers, I feel like a Kardashian.

1 year ago 4 0 0 0

I'll write you a letter of support!

1 year ago 1 0 0 0

X had too many weirdos and not enough science. Bluesky has more science.

1 year ago 7 1 1 0